港股異動丨京投交通科技(1522.HK)大漲逾17% 近期取得7.1億元國內地鐵相關項目
格隆匯6月23日丨京投交通科技(1522.HK)高開高走,現漲幅擴大至逾17%,報0.475港元,總市值10億港元。京投交通科技昨日盤後發佈公吿,近期先後取得紹興地鐵1號線弱電總集成項目(合同金額5.55億元人民幣)、紹興地鐵1號線屏蔽門項目(合同金額約7562萬元人民幣)、深圳地鐵16號線(合同金額約3471萬元人民幣)及12號線(中標金額約4121萬元人民幣)乘客信息系統項目。其中,紹興地鐵1號線弱電總集成項目是集團首次作為總集成商承攬的具有里程碑意義的項目,集團將透過此項目深度打造新區域樞紐、助力長三角軌道交通建設。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.